Evaluating the In Vitro Activity and Safety of Modified LfcinB Peptides as Potential Colon Anticancer Agents: Cell Line Studies and Insect-Based Toxicity Assessments
Karen J. Cárdenas-Martínez,
Andrea C. Barragán-Cárdenas,
Manuela de la Rosa-Arbeláez,
Claudia M. Parra-Giraldo,
Alejandra Ochoa-Zarzosa,
Joel E. Lopez-Meza,
Zuly J. Rivera-Monroy,
Ricardo Fierro-Medina,
Javier E. García-Castañeda
Affiliations
Karen J. Cárdenas-Martínez
†Department of Pharmacy, Universidad Nacional de Colombia, Bogotá, Colombia
Andrea C. Barragán-Cárdenas
‡Department of Biotechnology, Universidad Nacional de Colombia, Bogotá, Colombia
Manuela de la Rosa-Arbeláez
§Deparment of Chemistry, Universidad Nacional de Colombia, Bogotá, Colombia
Claudia M. Parra-Giraldo
Proteomics and Human Mycosis Unit, Infectious Diseases Research Group, Department of Microbiology, Pontificia Universidad Javeriana, Bogotá, Colombia
Alejandra Ochoa-Zarzosa
Multidisciplinary Centre for Studies in Biotechnology, Universidad Michoacana de San Nicolas de Hidalgo, Tarímbaro, México
Joel E. Lopez-Meza
Multidisciplinary Centre for Studies in Biotechnology, Universidad Michoacana de San Nicolas de Hidalgo, Tarímbaro, México
Zuly J. Rivera-Monroy
§Deparment of Chemistry, Universidad Nacional de Colombia, Bogotá, Colombia
Ricardo Fierro-Medina
§Deparment of Chemistry, Universidad Nacional de Colombia, Bogotá, Colombia
Javier E. García-Castañeda
†Department of Pharmacy, Universidad Nacional de Colombia, Bogotá, Colombia
